Moderna
MRNA
#1076
Rank
HK$170.67 B
Marketcap
HK$432.14
Share price
-0.90%
Change (1 day)
54.64%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$21.94 Billion

According to Moderna 's latest financial reports the company's total liabilities are HK$21.94 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Moderna - Total liabilities on balance sheet (from 2017 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$25.16 B-29.53%
2023-12-31HK$35.70 B-32.14%
2022-12-31HK$52.62 B-35.87%
2021-12-31HK$82.06 B121.64%
2020-12-31HK$37.02 B1046.61%
2019-12-31HK$3.22 B-4.53%
2018-12-31HK$3.38 B-5.73%
2017-12-31HK$3.58 B-19.58%
2016-12-31HK$4.46 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
HK$920.50 B 4,094.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$503.80 B 2,195.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
HK$607.36 B 2,667.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
HK$45.35 M-99.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
HK$0.34 B-98.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$32.67 B 48.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
HK$8.14 B-62.87%๐Ÿ‡บ๐Ÿ‡ธ USA